1. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis
   Yi Li et al, 2017, Oncology Reports CrossRef
2. Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors
   A. I. Chapoval et al, 2019, Russian Journal of Bioorganic Chemistry CrossRef
3. Safety and Efficacy of Immune Checkpoint Inhibitors in Children and Young Adults with Haematological Malignancies: Review and Future Perspectives
   Eleni Tsotridou et al, 2022, Cardiovascular & Hematological Agents in Medicinal Chemistry CrossRef
4. Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
   Wei Zhang et al, 2021, Bioengineered CrossRef
5. Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
   FEIFEI WU et al, 2016, International Journal of Oncology CrossRef
6. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
   Tongguo Shi et al, 2019, Cell Death & Disease CrossRef
7. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer
   Zheng-Shi Wang et al, 2016, Oncotarget CrossRef
8. T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting
   Xin Sun et al, 2020, Investigational New Drugs CrossRef
9. B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival
   Salwa Alhamad et al, 2023, Cancers CrossRef
10. B7-H3: A promising therapeutic target for autoimmune diseases
    Yuting Chen et al, 2020, Cellular Immunology CrossRef
11. Immunoregulatory protein B7‐H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
    Karine Flem‐Karlsen et al, 2017, Pigment Cell & Melanoma Research CrossRef
12. B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?
    Wei Zhang et al, 2021, Frontiers in Oncology CrossRef
13. B7-H3 Immune Checkpoint Protein in Human Cancer
    Karine Flem-Karlsen et al, 2020, Current Medicinal Chemistry CrossRef
14. Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway
    Yanfang Wang et al, 2020, Hematology CrossRef
15. Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy
    Bita Amir Taghavi et al, 2022, Molecules CrossRef
16. The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
    Xi-Yang Tang et al, 2022, Cancers CrossRef
17. Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies
    Massimo Giuliani et al, 2020, Cells CrossRef
18. The potentials of immune checkpoints for the treatment of blood malignancies
    Mohsen Alizadeh et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
19. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention
    Elizabeth Varghese et al, 2024, Cancer and Metastasis Reviews CrossRef
20. B7-H3 is related to tumor progression in ovarian cancer
    Jingjing Zhang et al, 2017, Oncology Reports CrossRef
21. The role of B7-H3 in tumors and its potential in clinical application
    Ranran Feng et al, 2021, International Immunopharmacology CrossRef
22. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
    Peixin Dong et al, 2018, Frontiers in Oncology CrossRef
23. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7 H3
    Xiao-wen Zhu et al, 2019, Biochemical and Biophysical Research Communications CrossRef
24. B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
    Minodora Desmirean et al, 2020, Journal of Clinical Medicine CrossRef